Insider · CIK 0001448698

Cherington Charles

Reports to the SEC for 3 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001448698

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-10	ERNAErnexa Therapeutics Inc.P Purchase	10% Owner	PPurchase	+4M sh	$0.50	+$2M	6,779,440
2026-02-10	ERNAErnexa Therapeutics Inc. · Warrants to Purchase Common StockP Purchase	10% Owner	PPurchase	+4M sh	—	—	4,000,000
2025-06-09	ERNAErnexa Therapeutics Inc.P Purchase	10% Owner	PPurchase	+21.2M sh	$0.10	+$2.22M	41,659,743
2025-04-02	ERNAErnexa Therapeutics Inc.P Purchase	10% Owner	PPurchase	+3.77M sh	$0.10	+$394K	20,401,602
2024-10-29	ERNAErnexa Therapeutics Inc.P Purchase	10% Owner	PPurchase	+5.42M sh	—	—	12,245,589
2024-10-29	ERNAErnexa Therapeutics Inc.P Purchase	10% Owner	PPurchase	+1.56M sh	—	—	13,808,577
2024-10-29	ERNAErnexa Therapeutics Inc.C Conversion	10% Owner	CConversion	+2.82M sh	$0.50	+$1.41M	16,628,123
2024-10-29	ERNAErnexa Therapeutics Inc. · Warrants (right to buy)S Sale	10% Owner	SSale	−3.13M sh	—	—	0
2024-10-29	ERNAErnexa Therapeutics Inc.P Purchase	10% Owner	PPurchase	+262K sh	—	—	818,221
2024-10-29	ERNAErnexa Therapeutics Inc.P Purchase	10% Owner	PPurchase	+4.77M sh	—	—	5,587,004
2024-10-29	ERNAErnexa Therapeutics Inc.P Purchase	10% Owner	PPurchase	+1.24M sh	—	—	6,824,766
2024-10-29	ERNAErnexa Therapeutics Inc. · 12.0% Senior Convertible Notes due September 24, 2025C Conversion	10% Owner	CConversion	—	—	—	0
2024-10-29	ERNAErnexa Therapeutics Inc. · 12.0% Senior Convertible Notes due December 12, 2028S Sale	10% Owner	SSale	—	—	—	0
2024-10-29	ERNAErnexa Therapeutics Inc. · 6.0% Senior Convertible Promissory Notes due 2028S Sale	10% Owner	SSale	—	—	—	0
2024-10-29	ERNAErnexa Therapeutics Inc. · Warrants (right to buy)S Sale	10% Owner	SSale	−524K sh	—	—	0
2024-10-29	ERNAErnexa Therapeutics Inc. · Warrants (right to buy)S Sale	10% Owner	SSale	−2.48M sh	—	—	0
2024-09-24	ERNAErnexa Therapeutics Inc.P Purchase	10% Owner	PPurchase	+4.77M sh	—	—	5,587,004
2024-09-24	ERNAErnexa Therapeutics Inc.P Purchase	10% Owner	PPurchase	+262K sh	—	—	818,221
2024-09-24	ERNAErnexa Therapeutics Inc. · Warrants (right to buy)S Sale	10% Owner	SSale	−524K sh	—	—	0
2024-09-24	ERNAErnexa Therapeutics Inc. · 6.0% Senior Convertible Promissory Notes due 2028S Sale	10% Owner	SSale	—	—	—	0
2024-09-24	ERNAErnexa Therapeutics Inc. · 12.0% Senior Convertible Notes due December 12, 2028S Sale	10% Owner	SSale	—	—	—	0
2024-09-24	ERNAErnexa Therapeutics Inc. · 12.0% Senior Convertible Notes due September 24, 2025P Purchase	10% Owner	PPurchase	—	$1368626.00	—	—
2024-09-24	ERNAErnexa Therapeutics Inc.P Purchase	10% Owner	PPurchase	+1.56M sh	—	—	13,808,577
2024-09-24	ERNAErnexa Therapeutics Inc.P Purchase	10% Owner	PPurchase	+5.42M sh	—	—	12,245,589
2024-09-24	ERNAErnexa Therapeutics Inc.P Purchase	10% Owner	PPurchase	+1.24M sh	—	—	6,824,766
2024-09-24	ERNAErnexa Therapeutics Inc. · Warrants (right to buy)S Sale	10% Owner	SSale	−3.13M sh	—	—	0
2024-09-24	ERNAErnexa Therapeutics Inc. · Warrants (right to buy)S Sale	10% Owner	SSale	−2.48M sh	—	—	0
2024-09-23	ERNAErnexa Therapeutics Inc. · Warrants (right to buy)P Purchase	10% Owner	PPurchase	+83.9K sh	—	—	2,475,524
2024-09-23	ERNAErnexa Therapeutics Inc. · 6.0% Senior Convertible Promissory Notes due 2028P Purchase	10% Owner	PPurchase	—	—	—	—
2024-09-23	ERNAErnexa Therapeutics Inc. · Warrants (right to buy)P Purchase	10% Owner	PPurchase	+83.9K sh	—	—	2,391,608
2024-09-23	ERNAErnexa Therapeutics Inc. · 6.0% Senior Convertible Promissory Notes due 2028P Purchase	10% Owner	PPurchase	—	—	—	—
2023-12-29	Comera Life Sciences Holdings, Inc.Warrants to Purchase Common StockP Purchase	10% Owner	PPurchase	+20.7M sh	—	—	20,650,908
2023-12-29	Comera Life Sciences Holdings, Inc.12.0% Senior Secured Convertible NotesP Purchase	10% Owner	PPurchase	—	$567900.00	—	—
2023-12-27	Comera Life Sciences Holdings, Inc.Series A Convertible Perpetual Preferred StockP Purchase	10% Owner	PPurchase	+3,895.53 sh	$500000.00	+$1.95B	3,895.53
2023-12-14	ERNAErnexa Therapeutics Inc. · 12.0% Senior Convertible NotesP Purchase	10% Owner	PPurchase	—	$3000000.00	—	—
2023-12-14	ERNAErnexa Therapeutics Inc. · Warrants (right to buy)P Purchase	10% Owner	PPurchase	+3.13M sh	$0.13	+$391K	3,125,976
2023-12-14	ERNAErnexa Therapeutics Inc. · Warrants (right to buy)H Expiration (Short)	10% Owner	HExpiration (Short)	−2.31M sh	—	—	0
2023-12-14	ERNAErnexa Therapeutics Inc. · Warrants (right to buy)P Purchase	10% Owner	PPurchase	+2.31M sh	—	—	2,307,692
2023-12-14	ERNAErnexa Therapeutics Inc. · Warrants (right to buy)H Expiration (Short)	10% Owner	HExpiration (Short)	−524K sh	—	—	0
2023-12-14	ERNAErnexa Therapeutics Inc. · Warrants (right to buy)P Purchase	10% Owner	PPurchase	+524K sh	—	—	523,512
2023-09-11	Comera Life Sciences Holdings, Inc.P Purchase	10% Owner	PPurchase	+2.05M sh	$0.51	+$1.05M	5,813,650
2023-09-11	Comera Life Sciences Holdings, Inc.Warrants to Purchase Common StockP Purchase	10% Owner	PPurchase	+5.13M sh	—	—	5,134,474
2023-07-31	Comera Life Sciences Holdings, Inc.Warrants to Purchase Common StockP Purchase	10% Owner	PPurchase	+2.2M sh	—	—	2,200,488
2023-07-31	Comera Life Sciences Holdings, Inc.P Purchase	10% Owner	PPurchase	+880K sh	$0.51	+$450K	3,759,861
2023-07-13	ERNAErnexa Therapeutics Inc. · Warrants (right to buy)P Purchase	10% Owner	PPurchase	+2.31M sh	$0.13	+$288K	2,307,692
2023-07-13	ERNAErnexa Therapeutics Inc. · 6.0% Senior Convertible Promissory Notes due 2028P Purchase	10% Owner	PPurchase	—	$3300000.00	—	—
2023-01-04	Comera Life Sciences Holdings, Inc.P Purchase	10% Owner	PPurchase	+743K sh	$1.23	+$914K	2,879,666
2023-01-04	Comera Life Sciences Holdings, Inc.Warrants to Purchase Common StockP Purchase	10% Owner	PPurchase	+743K sh	$0.25	+$186K	743,243
2022-12-02	ERNAErnexa Therapeutics Inc. · Warrants (right to buy)P Purchase	10% Owner	PPurchase	+524K sh	$0.13	+$65.4K	523,512
2022-12-02	ERNAErnexa Therapeutics Inc.P Purchase	10% Owner	PPurchase	+262K sh	$3.28	+$859K	556,465

Recent filings

Accepted (ET)
Feb 174
Cherington Charles0001104659-26-016680
SEC(opens sec.gov)
Jun 114
Cherington Charles0001104659-25-058644
SEC(opens sec.gov)
May 74/A
Cherington Charles0001104659-25-045416
SEC(opens sec.gov)
Apr 44
Cherington Charles0001104659-25-032060
SEC(opens sec.gov)
Nov 54
Cherington Charles0001104659-24-114222
SEC(opens sec.gov)

Companies

Address

200 BERKLEY STREET 26TH FLOOR

BOSTON, MA, 02116